Global Influenza Programme
We provide Member States with strategic guidance, technical support and coordination of activities essential to make their health systems better prepared against seasonal, zoonotic and pandemic influenza threats to populations and individuals.

Vaccine composition recommendations

Other news

All →

Publications

All →
Considerations for use of avian influenza A(‎H5)‎ vaccines during the interpandemic and emergence periods: report of a WHO virtual scientific consultation, September 2024

WHO conducted a virtual scientific expert consultation on A(H5) vaccines and vaccination. This report provides an overview of the landscape of A(H5) vaccines...

Respiratory syncytial virus sequencing considerations for an expanded Global Influenza Surveillance and Response System

In recent years, rapid progress has been made in the development of new pharmaceutical interventions against respiratory syncytial virus (RSV), including...

Surveillance for human infections with avian influenza A(‎H5)‎ viruses: objectives, case definitions, testing and reporting

The overall objective of continual global surveillance for human infection with avian influenza A(H5) viruses is to detect and characterize any influenza...

Progress of respiratory syncytial virus surveillance and disease burden estimation based on the Global Influenza Surveillance and Response System: meeting report, Lima, Peru, 22-26 April 2024

The WHO has implemented the RSV surveillance strategy based on GISRS since 2015. Based on the experiences gained in integrated surveillance of influenza...